Compound library / Fat Loss / Metabolic
Triple monoamine reuptake inhibitor (dopamine, norepinephrine, serotonin) originally developed for Alzheimer's/Parkinson's, repurposed in trials for obesity due to strong appetite-suppressant effects.
| Category | Fat Loss / Metabolic |
|---|---|
| Typical route | Oral |
| Half-life | ~8 days (very long, due to active metabolites) |
| Common dose range | 0.25-1 mg/day in published obesity trials |
| Typical cycle length | Trial durations of 6+ months; not established for general use |
BioHack Track models Tesofensine at a half-life of 192 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Oral tablet/capsule; no reconstitution needed.
Store at room temperature.
Not FDA-approved anywhere yet; raised heart rate and blood pressure in trials. Long half-life means side effects can persist for weeks after stopping.
Track Tesofensine in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Tesofensine — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.